India – Indian pharma to focus on quality to remain a world leader
The US Trade Representative (USTR) has questioned India for the country’s growing spurious medicine problem. According to the USTR report, nearly 20% of all...
Australia – Artificial Intelligence Can Save Pharmacovigilance in Australia
For healthcare professionals in Australia, pharmacovigilance is a mix of centralized and decentralized processes. The pillar of these processes is the spontaneous report. In...
USA – Indian drugmaker gets warning letter from FDA
The US Food and Drug Administration (FDA) hit Indian drugmaker Aurobindo with a warning letter for inadequately investigating batch failures related to its manufacturing...
China – Experts suggest new method for assessing imported generic drugs in China
According to researchers, a newly developed strategy could improve the quality of generic drugs by assessing process control and process risk. In addition to...
China – Clinical evaluation authority, plus guidelines for animal testing studies
The National Medical Products Administration (NMPA), China’s medical device market regulator, has revealed plans to set up a technical division focused on clinical evaluation...
Asia – Asia-Pacific Roundup: India okays a handful of FDCs as long saga continues
India’s Central Drugs Standard Control Organization (CDSCO) has deemed 31 fixed-dose combinations (FDCs) as rational some 14 years after India ordered the withdrawal of 294 FDCs...
India – Pharmaceutical supply disruptions predicted in India
The pharmaceutical industry in Tamil Nadu foresees the months ahead in 2021 will be critical for the production and supply of pharmaceuticals because the...
Australia – TGA international engagement strategy 2021-2025
The Therapeutic Goods Administration (TGA), as part of the Australian Department of Health, supports the Department's strategic priorities for an affordable, accessible, efficient and...
Asia – Asia-Pacific Roundup: Malaysia publishes guidance on manufacturing cell and gene therapies
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has released guidance about cell and gene therapy manufacturing facilities. The guidance describes the process for setting up...
China – China announces new guidelines for oncology drugmakers
The US has long been the leader in research and development in oncology, but homegrown Chinese drugmakers have jumped one hurdle after another in...
